| 注册
首页|期刊导航|中国比较医学杂志|基于表观遗传学机制探讨中医药防治高血压病的研究进展

基于表观遗传学机制探讨中医药防治高血压病的研究进展

郭巾楠 屈雯雯 雷凯凯 田婷婷 刘庆乐 高帅飞 范立华

中国比较医学杂志2026,Vol.36Issue(10):130-146,17.
中国比较医学杂志2026,Vol.36Issue(10):130-146,17.DOI:10.3969/j.issn.1671-7856.2026.10.013

基于表观遗传学机制探讨中医药防治高血压病的研究进展

Research progress on epigenetic mechanisms in the prevention and treatment of hypertension using traditional Chinese medicine

郭巾楠 1屈雯雯 1雷凯凯 2田婷婷 1刘庆乐 3高帅飞 3范立华3

作者信息

  • 1. 河南中医药大学,郑州 450008
  • 2. 黑龙江中医药大学,哈尔滨 150000
  • 3. 河南中医药大学第三附属医院,郑州 450008
  • 折叠

摘要

Abstract

Hypertension is a chronic cardiovascular syndrome characterized by the persistent elevation of systemic arterial blood pressure.Its pathogenesis involves dysregulation of multiple regulatory systems,including the nervous,humoral,metabolic,and immune systems.Recent studies have confirmed the role of epigenetic modifications in regulating gene expression via complex interactions including DNA methylation,histone modification,and non-coding RNAs.This regulation further mediates the crosstalk between genetic and environmental factors and participates in key pathological processes of hypertension,such as vascular endothelial injury,vascular smooth muscle cell proliferation,inflammatory response,and activation of the renin-angiotensin-aldosterone system.There is inherent consistency between the theories of traditional Chinese medicine(TCM)and the concept of epigenetics.TCM exhibits unique advantages in terms of hypertension treatment,including fewer adverse reactions,multi-targeted effects,and multi-mechanism regulation.Among TCM-based interventions,TCM monomers and their active components,as well as TCM compound prescriptions,can regulate blood pressure and protect target organs through epigenetic regulation of DNA methylation,histone modification,and non-coding RNAs.This further highlights the value of TCM in interventions for hypertension,although further scope for development remains.This review systematically summarizes recent relevant studies,providing a theoretical basis for the in-depth exploration of the pathogenesis of hypertension and its clinical diagnosis and treatment with TCM,thereby promoting basic research and the clinical translational application of TCM in hypertension management based on epigenetic regulation.

关键词

表观遗传学/高血压病/中医药/研究进展

Key words

epigenetics/hypertension/traditional Chinese medicine/research progress

分类

医药卫生

引用本文复制引用

郭巾楠,屈雯雯,雷凯凯,田婷婷,刘庆乐,高帅飞,范立华..基于表观遗传学机制探讨中医药防治高血压病的研究进展[J].中国比较医学杂志,2026,36(10):130-146,17.

基金项目

第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号) (国中医药人教函[2022]1号)

全国名老中医药专家传承工作室建设项目(国中医药人教函[2022]75号) (国中医药人教函[2022]75号)

河南省中医药研究专项(2025LHZX3002). (2025LHZX3002)

中国比较医学杂志

1671-7856

访问量0
|
下载量0
段落导航相关论文